I agree that this site is using cookies. You can find further informations here.
X
Nishiya, Yumi
30  results:
Search for persons X
?
1

Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conj..:

Suzuki, Hirokazu ; Nagase, Shotaro ; Saito, Chiemi...
Molecular Cancer Therapeutics.  23 (2024)  3 - p. 257-271 , 2024
Link: https://doi.org/10.1158/..
 
?
2

DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibo..:

Yamato, Michiko ; Hasegawa, Jun ; Maejima, Takanori...
Molecular Cancer Therapeutics.  21 (2022)  4 - p. 635-646 , 2022
Link: https://doi.org/10.1158/..
 
?
3

Estimation of fraction of drug metabolism by a single UDP‐g..:

Honda, Tomoyo ; Obuchi, Wataru ; Nishiya, Yumi...
Biopharmaceutics & Drug Disposition.  43 (2022)  5 - p. 213-217 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Quizartinib, a selective FLT3 inhibitor, maintains antileuk..:

Aikawa, Tomoya ; Togashi, Noriko ; Iwanaga, Koichi...
Oncotarget.  11 (2020)  11 - p. 943-955 , 2020
Link: https://doi.org/10.18632..
 
?
5

Identification of non-P450 enzymes involved in the metaboli..:

Nishiya, Yumi ; Suzuki, Eiko ; Ishizuka, Tomoko...
Drug Metabolism and Pharmacokinetics.  35 (2020)  1 - p. 45-55 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Effect of inter-individual variability in human liver cytoc..:

Kishino, Yuki ; Hasegawa, Tomoko ; Kato, Ayako...
Mutation Research/Genetic Toxicology and Environmental Mutagenesis.  838 (2019)  - p. 37-45 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Bioactivation of loxoprofen to a pharmacologically active m..:

Sawamura, Ryoko ; Sakurai, Hidetaka ; Wada, Naoya...
Biopharmaceutics & Drug Disposition.  36 (2015)  6 - p. 352-363 , 2015
Link: https://doi.org/10.1002/..
 
?
8

Pharmacokinetics of DS-5565, a Novel α2δ Ligand, in Rats an..:

Yamamura, Naotoshi ; Yamada, Makiko ; Takahashi, Makoto...
Neurology.  82 (2014)  10_supplement - p. , 2014
Link: https://doi.org/10.1212/..
 
?
9

Comparison of Human Cytochrome P450 Inhibition by the Thien..:

Hagihara, Katsunobu ; Nishiya, Yumi ; Kurihara, Atsushi...
Drug Metabolism and Pharmacokinetics.  23 (2008)  6 - p. 412-420 , 2008
Link: https://doi.org/10.2133/..
 
?
10

Enantioselective 2‐hydroxylation of RS‐8359, a selective an..:

Itoh, Kunio ; Nishiya, Yumi ; Takasaki, Wataru..
Chirality.  18 (2006)  8 - p. 592-598 , 2006
Link: https://doi.org/10.1002/..
 
?
11

Figure S4 from Raludotatug Deruxtecan, a CDH6-Targeting Ant..:

Hirokazu Suzuki ; Shotaro Nagase ; Chiemi Saito...
https://figshare.com/articles/figure/Figure_S4_from_Raludotatug_Deruxtecan_a_CDH6-Targeting_Antibody_Drug_Conjugate_with_a_DNA_Topoisomerase_I_Inhibitor_DXd_Is_Efficacious_in_Human_Ovarian_and_Kidney_Cancer_Models/25338019.  , 2024
Link: https://doi.org/10.1158/..
 
?
12

Table S3. from Raludotatug Deruxtecan, a CDH6-Targeting Ant..:

Hirokazu Suzuki ; Shotaro Nagase ; Chiemi Saito...
doi:10.1158/1535-7163.25338007.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
13

Figure S2 from Raludotatug Deruxtecan, a CDH6-Targeting Ant..:

Hirokazu Suzuki ; Shotaro Nagase ; Chiemi Saito...
doi:10.1158/1535-7163.25338025.v1.  , 2024
Link: https://doi.org/10.1158/..
 
?
14

Table S2 from Raludotatug Deruxtecan, a CDH6-Targeting Anti..:

Hirokazu Suzuki ; Shotaro Nagase ; Chiemi Saito...
https://figshare.com/articles/journal_contribution/Table_S2_from_Raludotatug_Deruxtecan_a_CDH6-Targeting_Antibody_Drug_Conjugate_with_a_DNA_Topoisomerase_I_Inhibitor_DXd_Is_Efficacious_in_Human_Ovarian_and_Kidney_Cancer_Models/25338010.  , 2024
Link: https://doi.org/10.1158/..
 
?
15

Figure S3 from Raludotatug Deruxtecan, a CDH6-Targeting Ant..:

Hirokazu Suzuki ; Shotaro Nagase ; Chiemi Saito...
doi:10.1158/1535-7163.25338022.v1.  , 2024
Link: https://doi.org/10.1158/..
 
1-15